Related Experiment Videos
Nortriptyline absorption in short bowel syndrome.
J E Broyles1, R O Brown, T H Self
1Department of Clinical Pharmacy, University of Tennessee, Memphis.
Summary
Patients with severe short bowel syndrome can achieve therapeutic nortriptyline levels with oral medication. This finding is significant for oral drug therapy in patients requiring parenteral nutrition due to gastrointestinal issues.
Area of Science:
- Pharmacology
- Gastroenterology
- Clinical Medicine
Background:
- Severe short bowel syndrome (SBS) often necessitates parenteral nutrition (PN) due to impaired nutrient and drug absorption.
- Oral drug therapy efficacy can be compromised in SBS patients because of a shortened gastrointestinal tract.
Observation:
- A case study involving a patient with SBS requiring PN was conducted.
- The patient was administered nortriptyline orally.
Findings:
- The patient successfully achieved therapeutic nortriptyline serum concentrations via the oral route.
- This suggests oral drug administration is feasible in select SBS patients on PN.
Implications:
- This case highlights the potential for effective oral drug therapy in SBS patients, even when dependent on PN.
- Further research may explore optimizing oral drug absorption and achieving therapeutic levels in SBS populations.
- This finding could lead to improved medication management strategies for patients with significant gastrointestinal compromise.